top of page

البريد الإلكتروني: bd@sidmexinovia.com

رقم الهاتف: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

الرئيسية >

Emtaf Tablet

Emtaf Tablet

Manufacturer/Marketed By : EMCURE PHARMACEUTICALS LTD

$20.80 $16.63

Emtaf tablet contains the active ingredient Emtricitabine/ tenofovir alafenamide. It is a combination of antiretroviral medication. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

EMTRICITABINE,TENOFOVIR ALAFENAMIDE

Active Pharmaceutical Ingredient

Emtaf Tablet

SKU EMCURE PHARMACEUTICALS LTD
السعر الأصلي

‏20.80 US$

سعر البيع

‏16.63 US$

Emtaf tablet contains the active ingredient Emtricitabine/ tenofovir alafenamide. It is a combination of antiretroviral medication. Emtricitabine belongs to the class of medication called nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide belongs to the class called nucleotide reverse transcriptase inhibitor (NtRTI). It is used in combination with other medicines to treat human immunodeficiency virus (HIV-1) infection in adults and adolescents 12 years of age and who weigh at least 35kg. They work by slowing the spread of HIV in the body. Do not take Emtaf tablet if you are allergic to Emtricitabine/ tenofovir alafenamide or any of the other ingredients. Get tested for HIV infection regularly while using this medicine. Do not miss any doses of this medicine or stop taking it. Missing doses may increase your risk of getting HIV infection.  This medicine does not prevent other sexually transmitted infections (STIs). Inform your physician if you have liver problems or suffer from liver disease, including hepatitis, kidney problems, and bone problems. Do not give this medicine to children aged 11 years or under.

Active Pharmaceutical Ingredient

EMTRICITABINE,TENOFOVIR ALAFENAMIDE

الاستخدامات

• HIV infection

فوائد

Emtricitabine and tenofovir alafenamide are nucleoside/nucleotide analog reverse transcriptase inhibitors, exhibiting their antiviral effect by competing with natural substrates and incorporating them into viral DNA, resulting in the termination of the DNA chain.

تأثيرات جانبية

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

الآثار الجانبية الأكثر شيوعًا

• Nausea, vomiting

الآثار الجانبية الشائعة

• Hepatitis B reactivation
• Increased risk of fracture
• Acute renal failure

كيفية الاستخدام

It is an orally available prescription drug. Your doctor will decide the dose and duration of Emtaf tablet based on the disease condition and other factors such as body weight and age. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with a glass of water. If you have difficulty in swallowing the tablet whole, you can split it in half after consulting with your doctor.

نصائح السلامة

• Breast Feeding: Breastfeeding is not recommended in patients taking Emtaf tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
• Alcohol: It is unsafe to drink alcohol while taking Emtaf tablet. It may reduce the effectiveness of the drug and can cause toxic side effects.
• Liver: Emtaf tablet should be cautiously administered in patients with liver diseases. Dose adjustments are necessary. However, inform your physician if you have any liver diseases before initating the therapy.
• Lungs: It is unknown whether Emtaf tablet is safe to be administer in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.
• Driving: Emtaf tablet can cause dizziness. It is recommended to avoid driving and operating heavy machinery during the treatment.
• Pregnancy: There is limited information on the use of  Emtaf tablet during pregnancy. Inform your physician if you are pregnant or planning to get pregnant during the treatment.

تنصل

تسعى شركة Sidmex Inovia جاهدة لتوفير معلومات دقيقة وموثوقة؛ ومع ذلك، فإن جميع المحتويات الموجودة على هذا الموقع الإلكتروني، بما في ذلك أوصاف المنتجات ومكوناتها، هي لأغراض إعلامية فقط ولا ينبغي اعتبارها بديلاً عن المشورة الطبية المهنية أو التشخيص أو العلاج.

يُنصح المستخدمون باستشارة أخصائي رعاية صحية مؤهل قبل اتخاذ أي قرارات طبية. لا ينبغي استخدام المعلومات المقدمة للتشخيص الذاتي أو العلاج الذاتي.

جميع المنتجات المذكورة مخصصة حصراً لأغراض التعاملات التجارية بين الشركات والاستفسارات بالجملة. لا تشجع شركة سيدمكس إينوفيا الاستخدام المباشر من قبل المستهلكين، وتهدف إلى دعم العلاقة بين أخصائي الرعاية الصحية والمريض، لا استبدالها.

جميع أسماء المنتجات والعلامات التجارية والأسماء التجارية مملوكة لأصحابها، ولا يعني استخدامها أي انتماء أو تأييد. لا تتحمل شركة سيدمكس إينوفيا أي مسؤولية عن أي تبعات ناتجة عن استخدام المعلومات الواردة في هذا الموقع الإلكتروني.

bottom of page